John D. Salamone - Publications

Affiliations: 
University of Connecticut, Storrs, CT, United States 
Area:
DA and motivation

246/291 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Rotolo RA, Ecevitoglu A, Presby RE, Lindgren H, Mombereau C, Nicholas C, Moore A, Edelstein GA, Correa M, Salamone JD. Effort-related effects of chronic administration of the DA D receptor antagonist haloperidol via subcutaneous programmable minipumps: Reversal by co-administration of the adenosine A2A antagonist istradefylline. Psychopharmacology. PMID 37615683 DOI: 10.1007/s00213-023-06439-y  0.379
2022 Kouhnavardi S, Ecevitoglu A, Dragačević V, Sanna F, Arias-Sandoval E, Kalaba P, Kirchhofer M, Lubec J, Niello M, Holy M, Zehl M, Pillwein M, Wackerlig J, Murau R, Mohrmann A, ... ... Salamone JD, et al. A Novel and Selective Dopamine Transporter Inhibitor, -MK-26, Promotes Hippocampal Synaptic Plasticity and Restores Effort-Related Motivational Dysfunctions. Biomolecules. 12. PMID 35883437 DOI: 10.3390/biom12070881  0.371
2022 Ren N, Carratala-Ros C, Ecevitoglu A, Rotolo RA, Edelstein GA, Presby RE, Stevenson IH, Chrobak JJ, Salamone JD. Effects of the dopamine depleting agent tetrabenazine on detailed temporal parameters of effort-related choice responding. Journal of the Experimental Analysis of Behavior. PMID 35344599 DOI: 10.1002/jeab.754  0.406
2022 Salamone JD, Ecevitoglu A, Carratala-Ros C, Presby RE, Edelstein GA, Fleeher R, Rotolo RA, Meka N, Srinath S, Masthay JC, Correa M. Complexities and paradoxes in understanding the role of dopamine in incentive motivation and instrumental action: Exertion of effort vs. anhedonia. Brain Research Bulletin. 182: 57-66. PMID 35151797 DOI: 10.1016/j.brainresbull.2022.01.019  0.353
2021 Carratalá-Ros C, Olivares-García R, Martínez-Verdú A, Arias-Sandoval E, Salamone JD, Correa M. Energizing effects of bupropion on effortful behaviors in mice under positive and negative test conditions: modulation of DARPP-32 phosphorylation patterns. Psychopharmacology. PMID 34498115 DOI: 10.1007/s00213-021-05950-4  0.327
2021 Carratalá-Ros C, López-Cruz L, Martínez-Verdú A, Olivares-García R, Salamone JD, Correa M. Impact of Fluoxetine on Behavioral Invigoration of Appetitive and Aversively Motivated Responses: Interaction With Dopamine Depletion. Frontiers in Behavioral Neuroscience. 15: 700182. PMID 34305547 DOI: 10.3389/fnbeh.2021.700182  0.387
2020 Rotolo RA, Presby RE, Tracy O, Asar S, Yang JH, Correa M, Murray F, Salamone JD. The novel atypical dopamine transport inhibitor CT-005404 has pro-motivational effects in neurochemical and inflammatory models of effort-based dysfunctions related to psychopathology. Neuropharmacology. 108325. PMID 32956676 DOI: 10.1016/j.neuropharm.2020.108325  0.409
2020 Pardo M, Paul NE, Collins-Praino LE, Salamone JD, Correa M. The non-selective adenosine antagonist theophylline reverses the effects of dopamine antagonism on tremor, motor activity and effort-based decision-making. Pharmacology, Biochemistry, and Behavior. 173035. PMID 32910928 DOI: 10.1016/J.Pbb.2020.173035  0.794
2020 Rotolo RA, Kalaba P, Dragacevic V, Presby RE, Neri J, Robertson E, Yang JH, Correa M, Bakulev V, Volkova NN, Pifl C, Lubec G, Salamone JD. Behavioral and dopamine transporter binding properties of the modafinil analog (S, S)-CE-158: reversal of the motivational effects of tetrabenazine and enhancement of progressive ratio responding. Psychopharmacology. PMID 32770257 DOI: 10.1007/S00213-020-05625-6  0.444
2020 Yang JH, Presby RE, Cayer S, Rotolo RA, Perrino PA, Fitch RH, Correa M, Chesler EJ, Salamone JD. Effort-related decision making in humanized COMT mice: Effects of ValMet polymorphisms and possible implications for negative symptoms in humans. Pharmacology, Biochemistry, and Behavior. 196: 172975. PMID 32593787 DOI: 10.1016/J.Pbb.2020.172975  0.589
2020 Yang JH, Presby RE, Rotolo RA, Quiles T, Okifo K, Zorda E, Fitch RH, Correa M, Salamone JD. The dopamine depleting agent tetrabenazine alters effort-related decision making as assessed by mouse touchscreen procedures. Psychopharmacology. PMID 32561947 DOI: 10.1007/S00213-020-05578-W  0.444
2020 Correa M, Pardo M, Carratalá-Ros C, Martínez-Verdú A, Salamone JD. Preference for vigorous exercise versus sedentary sucrose drinking: an animal model of anergia induced by dopamine receptor antagonism. Behavioural Pharmacology. PMID 32141919 DOI: 10.1097/FBP.0000000000000556  0.481
2020 Presby RE, Rotolo RA, Yang JH, Correa M, Salamone JD. Lisdexamfetamine suppresses instrumental and consummatory behaviors supported by foods with varying degrees of palatability: Exploration of a binge-like eating model. Pharmacology, Biochemistry, and Behavior. 172851. PMID 31931017 DOI: 10.1016/j.pbb.2020.172851  0.375
2019 Carratalá-Ros C, López-Cruz L, SanMiguel N, Ibáñez-Marín P, Martínez-Verdú A, Salamone JD, Correa M. Preference for Exercise vs. More Sedentary Reinforcers: Validation of an Animal Model of Tetrabenazine-Induced Anergia. Frontiers in Behavioral Neuroscience. 13: 289. PMID 32082126 DOI: 10.3389/fnbeh.2019.00289  0.446
2019 SanMiguel N, López-Cruz L, Müller CE, Salamone JD, Correa M. Caffeine modulates voluntary alcohol intake in mice depending on the access conditions: Involvement of adenosine receptors and the role of individual differences. Pharmacology, Biochemistry, and Behavior. 186: 172789. PMID 31499144 DOI: 10.1016/J.Pbb.2019.172789  0.38
2019 Yang JH, Presby RE, Jarvie AA, Rotolo RA, Fitch RH, Correa M, Salamone JD. Pharmacological studies of effort-related decision making using mouse touchscreen procedures: effects of dopamine antagonism do not resemble reinforcer devaluation by removal of food restriction. Psychopharmacology. PMID 31392358 DOI: 10.1007/s00213-019-05343-8  0.434
2019 Rotolo RA, Dragacevic V, Kalaba P, Urban E, Zehl M, Roller A, Wackerlig J, Langer T, Pistis M, De Luca MA, Caria F, Schwartz R, Presby RE, Yang JH, Samels S, ... ... Salamone JD, et al. The Novel Atypical Dopamine Uptake Inhibitor -CE-123 Partially Reverses the Effort-Related Effects of the Dopamine Depleting Agent Tetrabenazine and Increases Progressive Ratio Responding. Frontiers in Pharmacology. 10: 682. PMID 31316379 DOI: 10.3389/fphar.2019.00682  0.517
2018 Le Heron C, Holroyd CB, Salamone J, Husain M. Brain mechanisms underlying apathy. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 30366958 DOI: 10.1136/jnnp-2018-318265  0.301
2018 Correa M, SanMiguel N, López-Cruz L, Carratalá-Ros C, Olivares-García R, Salamone JD. Caffeine Modulates Food Intake Depending on the Context That Gives Access to Food: Comparison With Dopamine Depletion. Frontiers in Psychiatry. 9: 411. PMID 30237771 DOI: 10.3389/fpsyt.2018.00411  0.425
2018 Salamone JD, Correa M, Ferrigno S, Yang JH, Rotolo RA, Presby RE. The Psychopharmacology of Effort-Related Decision Making: Dopamine, Adenosine, and Insights into the Neurochemistry of Motivation. Pharmacological Reviews. 70: 747-762. PMID 30209181 DOI: 10.1124/pr.117.015107  0.408
2018 López-Cruz L, Salamone JD, Correa M. Caffeine and Selective Adenosine Receptor Antagonists as New Therapeutic Tools for the Motivational Symptoms of Depression. Frontiers in Pharmacology. 9: 526. PMID 29910727 DOI: 10.3389/fphar.2018.00526  0.371
2018 Acquas E, Salamone JD, Correa M. Editorial: Ethanol, Its Active Metabolites, and Their Mechanisms of Action: Neurophysiological and Behavioral Effects. Frontiers in Behavioral Neuroscience. 12: 95. PMID 29867394 DOI: 10.3389/fnbeh.2018.00095  0.347
2018 SanMiguel N, Pardo M, Carratalá-Ros C, López-Cruz L, Salamone JD, Correa M. Individual differences in the energizing effects of caffeine on effort-based decision-making tests in rats. Pharmacology, Biochemistry, and Behavior. 169: 27-34. PMID 29655598 DOI: 10.1016/j.pbb.2018.04.004  0.495
2018 Salamone JD, Correa M, Yang JH, Rotolo R, Presby R. Dopamine, Effort-Based Choice, and Behavioral Economics: Basic and Translational Research. Frontiers in Behavioral Neuroscience. 12: 52. PMID 29628879 DOI: 10.3389/fnbeh.2018.00052  0.448
2018 López-Cruz L, San Miguel N, Carratalá-Ros C, Monferrer L, Salamone JD, Correa M. Dopamine depletion shifts behavior from activity based reinforcers to more sedentary ones and adenosine receptor antagonism reverses that shift: Relation to ventral striatum DARPP32 phosphorylation patterns. Neuropharmacology. PMID 29408363 DOI: 10.1016/j.neuropharm.2018.01.034  0.535
2018 Contreras-Mora H, Rowland MA, Yohn SE, Correa M, Salamone JD. Partial reversal of the effort-related motivational effects of tetrabenazine with the MAO-B inhibitor deprenyl (selegiline): Implications for treating motivational dysfunctions. Pharmacology, Biochemistry, and Behavior. PMID 29309800 DOI: 10.1016/j.pbb.2018.01.001  0.427
2018 Salamone JD, Correa M. Neurobiology and pharmacology of activational and effort-related aspects of motivation: rodent studies Current Opinion in Behavioral Sciences. 22: 114-120. DOI: 10.1016/J.COBEHA.2018.01.026  0.379
2018 Salamone J, Correa M, Yohn S, Rotolo R, Yang J, Presby R. 250. Anergia and Effort-Related Aspects of Motivational Dysfunction in Animal Models of Depressive Symptoms: The Role of Mesolimbic Dopamine and Related Circuitry Biological Psychiatry. 83: S101. DOI: 10.1016/j.biopsych.2018.02.269  0.377
2017 Yohn SE, Reynolds S, Tripodi G, Correa M, Salamone JD. The monoamine-oxidase B inhibitor deprenyl increases selection of high-effort activity in rats tested on a progressive ratio/chow feeding choice procedure: Implications for treating motivational dysfunctions. Behavioural Brain Research. PMID 29292157 DOI: 10.1016/j.bbr.2017.12.039  0.511
2017 Yohn SE, Gorka D, Mistry A, Collins S, Qian E, Correa M, Manchanda A, Bogner RH, Salamone JD. Oral Ingestion and Intraventricular Injection of Curcumin Attenuates the Effort-Related Effects of the VMAT-2 Inhibitor Tetrabenazine: Implications for Motivational Symptoms of Depression. Journal of Natural Products. PMID 28905625 DOI: 10.1021/acs.jnatprod.7b00425  0.396
2017 Yohn SE, Alberati D, Correa M, Salamone JD. Assessment of a glycine uptake inhibitor in animal models of effort-related choice behavior: implications for motivational dysfunctions. Psychopharmacology. PMID 28083675 DOI: 10.1007/s00213-016-4523-3  0.448
2016 López-Cruz L, Carbó-Gas M, Pardo M, Bayarri P, Valverde O, Ledent C, Salamone JD, Correa M. Adenosine A2A receptor deletion affects social behaviors and anxiety in mice: involvement of anterior cingulate cortex and amygdala. Behavioural Brain Research. PMID 28007538 DOI: 10.1016/j.bbr.2016.12.020  0.307
2016 López-Cruz L, San-Miguel N, Bayarri P, Baqi Y, Müller CE, Salamone JD, Correa M. Ethanol and Caffeine Effects on Social Interaction and Recognition in Mice: Involvement of Adenosine A2A and A1 Receptors. Frontiers in Behavioral Neuroscience. 10: 206. PMID 27853423 DOI: 10.3389/Fnbeh.2016.00206  0.358
2016 Long LL, Podurgiel SJ, Haque AF, Errante EL, Chrobak JJ, Salamone JD. Subthalamic and Cortical Local Field Potentials Associated with Pilocarpine-Induced Oral Tremor in the Rat. Frontiers in Behavioral Neuroscience. 10: 123. PMID 27378874 DOI: 10.3389/Fnbeh.2016.00123  0.422
2016 Yohn SE, Errante E, Rosenbloom-Snow A, Somerville M, Rowland M, Tokarski K, Zafar N, Correa M, Salamone JD. Blockade of uptake for dopamine, but not norepinephrine or 5-HT, increases selection of high effort instrumental activity: Implications for treatment of effort-related motivational symptoms in psychopathology. Neuropharmacology. PMID 27329556 DOI: 10.1016/j.neuropharm.2016.06.018  0.488
2016 Yohn SE, Gogoj A, Haque A, Lopez-Cruz L, Haley A, Huxley P, Baskin P, Correa M, Salamone JD. Evaulation of The Effort-Related Motivational Effects Of The Novel Dopamine Uptake Inhibitor Prx-14040. Pharmacology, Biochemistry, and Behavior. PMID 27296079 DOI: 10.1016/j.pbb.2016.06.004  0.515
2016 Salamone JD, Yohn SE, López-Cruz L, San Miguel N, Correa M. Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology. Brain : a Journal of Neurology. 139: 1325-47. PMID 27189581 DOI: 10.1093/brain/aww050  0.352
2016 Salamone JD, Correa M, Yohn S, Cruz LL, Miguel NS, Alatorre L. The Pharmacology of Effort-Related Choice Behavior: Dopamine, Depression, and Individual Differences. Behavioural Processes. PMID 26899746 DOI: 10.1016/j.beproc.2016.02.008  0.477
2016 Salamone JD. Dopamine, effort, and behavioral activation: animal models of effort-related motivational symptoms in psychopathology Intrinsic Activity. 4: A13.13. DOI: 10.25006/IA.4.S2-A13.13  0.305
2015 Yohn SE, Lopez-Cruz L, Hutson PH, Correa M, Salamone JD. Effects of lisdexamfetamine and s-citalopram, alone and in combination, on effort-related choice behavior in the rat. Psychopharmacology. PMID 26694811 DOI: 10.1007/s00213-015-4176-7  0.34
2015 Podurgiel SJ, Yohn SE, Dortche K, Correa M, Salamone JD. The MAO-B inhibitor deprenyl reduces the oral tremor and the dopamine depletion induced by the VMAT-2 inhibitor tetrabenazine. Behavioural Brain Research. PMID 26590367 DOI: 10.1016/j.bbr.2015.11.008  0.519
2015 Correa M, Pardo M, Bayarri P, López-Cruz L, San Miguel N, Valverde O, Ledent C, Salamone JD. Choosing voluntary exercise over sucrose consumption depends upon dopamine transmission: effects of haloperidol in wild type and adenosine A2AKO mice. Psychopharmacology. PMID 26554387 DOI: 10.1007/s00213-015-4127-3  0.473
2015 Podurgiel SJ, Spencer T, Kovner R, Baqi Y, Müller CE, Correa M, Salamone JD. Induction of oral tremor in mice by the acetylcholinesterase inhibitor galantamine: Reversal with adenosine A2A antagonism. Pharmacology, Biochemistry, and Behavior. PMID 26459156 DOI: 10.1016/J.Pbb.2015.10.008  0.395
2015 Salamone JD, Pardo M, Yohn SE, López-Cruz L, SanMiguel N, Correa M. Mesolimbic Dopamine and the Regulation of Motivated Behavior. Current Topics in Behavioral Neurosciences. PMID 26323245 DOI: 10.1007/7854_2015_383  0.483
2015 Yohn SE, Collins SL, Contreras-Mora HM, Errante EL, Rowland MA, Correa M, Salamone JD. Not All Antidepressants are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26105139 DOI: 10.1038/npp.2015.188  0.468
2015 Yohn SE, Santerre JL, Nunes EJ, Kozak R, Podurgiel SJ, Correa M, Salamone JD. The role of dopamine D1 receptor transmission in effort-related choice behavior: Effects of D1 agonists. Pharmacology, Biochemistry, and Behavior. 135: 217-26. PMID 26022661 DOI: 10.1016/J.Pbb.2015.05.003  0.845
2015 Podurgiel SJ, Milligan MN, Yohn SE, Purcell LJ, Contreras-Mora HM, Correa M, Salamone JD. Fluoxetine Administration Exacerbates Oral Tremor and Striatal Dopamine Depletion in a Rodent Pharmacological Model of Parkinsonism. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 2240-7. PMID 25759301 DOI: 10.1038/npp.2015.69  0.446
2015 Pardo M, López-Cruz L, Miguel NS, Salamone JD, Correa M. Selection of sucrose concentration depends on the effort required to obtain it: studies using tetrabenazine, D1, D2, and D3 receptor antagonists. Psychopharmacology. 232: 2377-91. PMID 25647696 DOI: 10.1007/s00213-015-3872-7  0.504
2015 Yohn SE, Thompson C, Randall PA, Lee CA, Müller CE, Baqi Y, Correa M, Salamone JD. The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion. Psychopharmacology. 232: 1313-23. PMID 25323625 DOI: 10.1007/S00213-014-3766-0  0.779
2015 Correa M, SanMiguel N, López-Cruz L, Carratalà C, Camañes J, Perez-García JM, Monferrer L, Salamone JD. SY02-4IMPACT OF DOPAMINE DEPLETION OR ENHANCEMENT ON ETHANOL CONSUMPTION IN RATS: FREE VERSUS WORK-MEDIATED ACCESS Alcohol and Alcoholism. 50: i4.1-i4. DOI: 10.1093/alcalc/agv076.07  0.321
2014 Randall PA, Lee CA, Podurgiel SJ, Hart E, Yohn SE, Jones M, Rowland M, López-Cruz L, Correa M, Salamone JD. Bupropion increases selection of high effort activity in rats tested on a progressive ratio/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 18. PMID 25575584 DOI: 10.1093/Ijnp/Pyu017  0.839
2014 Salamone JD, Koychev I, Correa M, McGuire P. Neurobiological basis of motivational deficits in psychopathology. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 25435083 DOI: 10.1016/J.Euroneuro.2014.08.014  0.34
2014 Randall PA, Lee CA, Nunes EJ, Yohn SE, Nowak V, Khan B, Shah P, Pandit S, Vemuri VK, Makriyannis A, Baqi Y, Müller CE, Correa M, Salamone JD. The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice task: reversal with antidepressant drugs. Plos One. 9: e99320. PMID 24937131 DOI: 10.1371/Journal.Pone.0099320  0.818
2014 López-Cruz L, Pardo M, Salamone JD, Correa M. Differences between the nonselective adenosine receptor antagonists caffeine and theophylline in motor and mood effects: studies using medium to high doses in animal models. Behavioural Brain Research. 270: 213-22. PMID 24859174 DOI: 10.1016/j.bbr.2014.05.020  0.482
2014 Nunes EJ, Randall PA, Estrada A, Epling B, Hart EE, Lee CA, Baqi Y, Müller CE, Correa M, Salamone JD. Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/ chow feeding choice task. Psychopharmacology. 231: 727-36. PMID 24136220 DOI: 10.1007/S00213-013-3285-4  0.806
2014 Salamone JD, Podurgiel S, Collins-Praino LE, Correa M. Physiological and Behavioral Assessment of Tremor in Rodents Movement Disorders: Genetics and Models: Second Edition. 631-640. DOI: 10.1016/B978-0-12-405195-9.00038-X  0.65
2013 López-Cruz L, Salamone JD, Correa M. The Impact of Caffeine on the Behavioral Effects of Ethanol Related to Abuse and Addiction: A Review of Animal Studies. Journal of Caffeine Research. 3: 9-21. PMID 24761272 DOI: 10.1089/jcr.2013.0003  0.355
2013 Nunes EJ, Randall PA, Hart EE, Freeland C, Yohn SE, Baqi Y, Müller CE, López-Cruz L, Correa M, Salamone JD. Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 19120-30. PMID 24305809 DOI: 10.1523/Jneurosci.2730-13.2013  0.834
2013 Podurgiel SJ, Nunes EJ, Yohn SE, Barber J, Thompson A, Milligan M, Lee CA, López-Cruz L, Pardo M, Valverde O, Lendent C, Baqi Y, Müller CE, Correa M, Salamone JD. The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor. Neuroscience. 250: 507-19. PMID 23867769 DOI: 10.1016/J.Neuroscience.2013.07.008  0.485
2013 Pardo M, Betz AJ, San Miguel N, López-Cruz L, Salamone JD, Correa M. Acetate as an active metabolite of ethanol: studies of locomotion, loss of righting reflex, and anxiety in rodents. Frontiers in Behavioral Neuroscience. 7: 81. PMID 23847487 DOI: 10.3389/fnbeh.2013.00081  0.745
2013 Segovia KN, Vontell R, López-Cruz L, Salamone JD, Correa M. c-Fos immunoreactivity in prefrontal, basal ganglia and limbic areas of the rat brain after central and peripheral administration of ethanol and its metabolite acetaldehyde. Frontiers in Behavioral Neuroscience. 7: 48. PMID 23745109 DOI: 10.3389/Fnbeh.2013.00048  0.829
2013 McLaughlin PJ, Thakur GA, Vemuri VK, McClure ED, Brown CM, Winston KM, Wood JT, Makriyannis A, Salamone JD. Behavioral effects of the novel potent cannabinoid CB1 agonist AM 4054. Pharmacology, Biochemistry, and Behavior. 109: 16-22. PMID 23603029 DOI: 10.1016/J.Pbb.2013.04.011  0.684
2013 Collins-Praino LE, Paul NE, Ledgard F, Podurgiel SJ, Kovner R, Baqi Y, Müller CE, Senatus PB, Salamone JD. Deep brain stimulation of the subthalamic nucleus reverses oral tremor in pharmacological models of parkinsonism: interaction with the effects of adenosine A2A antagonism. The European Journal of Neuroscience. 38: 2183-91. PMID 23600953 DOI: 10.1111/Ejn.12212  0.732
2013 Nunes EJ, Randall PA, Podurgiel S, Correa M, Salamone JD. Nucleus accumbens neurotransmission and effort-related choice behavior in food motivation: effects of drugs acting on dopamine, adenosine, and muscarinic acetylcholine receptors. Neuroscience and Biobehavioral Reviews. 37: 2015-25. PMID 23583616 DOI: 10.1016/J.Neubiorev.2013.04.002  0.849
2013 Salamone JD, Correa M. Insulin and ventral tegmental dopamine: what's impaired and what's intact? Cell Metabolism. 17: 469-70. PMID 23562071 DOI: 10.1016/j.cmet.2013.03.011  0.41
2013 Pardo M, López-Cruz L, Valverde O, Ledent C, Baqi Y, Müller CE, Salamone JD, Correa M. Effect of subtype-selective adenosine receptor antagonists on basal or haloperidol-regulated striatal function: studies of exploratory locomotion and c-Fos immunoreactivity in outbred and A(2A)R KO mice. Behavioural Brain Research. 247: 217-26. PMID 23557694 DOI: 10.1016/J.Bbr.2013.03.035  0.495
2013 Podurgiel S, Collins-Praino LE, Yohn S, Randall PA, Roach A, Lobianco C, Salamone JD. Tremorolytic effects of safinamide in animal models of drug-induced parkinsonian tremor. Pharmacology, Biochemistry, and Behavior. 105: 105-11. PMID 23360954 DOI: 10.1016/J.Pbb.2013.01.015  0.846
2013 Salamone JD, Correa M. Dopamine and food addiction: lexicon badly needed. Biological Psychiatry. 73: e15-24. PMID 23177385 DOI: 10.1016/j.biopsych.2012.09.027  0.405
2013 Salamone JD, Collins-Praino LE, Pardo M, Podurgiel SJ, Baqi Y, Müller CE, Schwarzschild MA, Correa M. Conditional neural knockout of the adenosine A(2A) receptor and pharmacological A(2A) antagonism reduce pilocarpine-induced tremulous jaw movements: studies with a mouse model of parkinsonian tremor. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 972-7. PMID 22947264 DOI: 10.1016/J.Euroneuro.2012.08.004  0.742
2013 Salamone JD, Nunes EJ, Randall PA, Yohn SE, Merce C. S.2.1 - DEVELOPMENT OF ANIMAL MODELS OF THE EFFORT-RELATED SYMPTOMS OF DEPRESSION Behavioural Pharmacology. 24: e3. DOI: 10.1097/01.Fbp.0000434686.35248.7A  0.739
2013 Salamone JD, Correa M, Randall PA, Nunes EJ, Pardo M, Lopez-Cruz L. The role of adenosine in the ventral striatal circuits regulating behavioral activation and effort-related decision making: Importance for normal and pathological aspects of motivation Adenosine: a Key Link Between Metabolism and Brain Activity. 493-512. DOI: 10.1007/978-1-4614-3903-5_23  0.75
2012 Salamone JD, Correa M. The mysterious motivational functions of mesolimbic dopamine. Neuron. 76: 470-85. PMID 23141060 DOI: 10.1016/j.neuron.2012.10.021  0.456
2012 Randall PA, Pardo M, Nunes EJ, López Cruz L, Vemuri VK, Makriyannis A, Baqi Y, Müller CE, Correa M, Salamone JD. Dopaminergic modulation of effort-related choice behavior as assessed by a progressive ratio chow feeding choice task: pharmacological studies and the role of individual differences. Plos One. 7: e47934. PMID 23110135 DOI: 10.1371/Journal.Pone.0047934  0.836
2012 Collins-Praino LE, Podurgiel SJ, Kovner R, Randall PA, Salamone JD. Extracellular GABA in globus pallidus increases during the induction of oral tremor by haloperidol but not by muscarinic receptor stimulation. Behavioural Brain Research. 234: 129-35. PMID 22728308 DOI: 10.1016/J.Bbr.2012.06.011  0.835
2012 Santerre JL, Nunes EJ, Kovner R, Leser CE, Randall PA, Collins-Praino LE, Lopez Cruz L, Correa M, Baqi Y, Müller CE, Salamone JD. The novel adenosine A(2A) antagonist prodrug MSX-4 is effective in animal models related to motivational and motor functions. Pharmacology, Biochemistry, and Behavior. 102: 477-87. PMID 22705392 DOI: 10.1016/J.Pbb.2012.06.009  0.835
2012 Segovia KN, Correa M, Lennington JB, Conover JC, Salamone JD. Changes in nucleus accumbens and neostriatal c-Fos and DARPP-32 immunoreactivity during different stages of food-reinforced instrumental training. The European Journal of Neuroscience. 35: 1354-67. PMID 22462413 DOI: 10.1111/J.1460-9568.2012.08036.X  0.803
2012 Salamone JD, Correa M, Nunes EJ, Randall PA, Pardo M. The behavioral pharmacology of effort-related choice behavior: dopamine, adenosine and beyond. Journal of the Experimental Analysis of Behavior. 97: 125-46. PMID 22287808 DOI: 10.1901/Jeab.2012.97-125  0.828
2012 Pardo M, Lopez-Cruz L, Valverde O, Ledent C, Baqi Y, Müller CE, Salamone JD, Correa M. Adenosine A2A receptor antagonism and genetic deletion attenuate the effects of dopamine D2 antagonism on effort-based decision making in mice. Neuropharmacology. 62: 2068-77. PMID 22261384 DOI: 10.1016/J.Neuropharm.2011.12.033  0.486
2012 Collins LE, Sager TN, Sams AG, Pennarola A, Port RG, Shahriari M, Salamone JD. The novel adenosine A2A antagonist Lu AA47070 reverses the motor and motivational effects produced by dopamine D2 receptor blockade. Pharmacology, Biochemistry, and Behavior. 100: 498-505. PMID 22037410 DOI: 10.1016/J.Pbb.2011.10.015  0.39
2012 Correa M, Salamone JD, Segovia KN, Pardo M, Longoni R, Spina L, Peana AT, Vinci S, Acquas E. Piecing together the puzzle of acetaldehyde as a neuroactive agent. Neuroscience and Biobehavioral Reviews. 36: 404-30. PMID 21824493 DOI: 10.1016/J.Neubiorev.2011.07.009  0.779
2011 Lennington JB, Pope S, Goodheart AE, Drozdowicz L, Daniels SB, Salamone JD, Conover JC. Midbrain dopamine neurons associated with reward processing innervate the neurogenic subventricular zone. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 13078-87. PMID 21917791 DOI: 10.1523/Jneurosci.1197-11.2011  0.346
2011 Segovia KN, Correa M, Salamone JD. Slow phasic changes in nucleus accumbens dopamine release during fixed ratio acquisition: a microdialysis study. Neuroscience. 196: 178-88. PMID 21884757 DOI: 10.1016/J.Neuroscience.2011.07.078  0.833
2011 Collins-Praino LE, Paul NE, Rychalsky KL, Hinman JR, Chrobak JJ, Senatus PB, Salamone JD. Pharmacological and physiological characterization of the tremulous jaw movement model of parkinsonian tremor: potential insights into the pathophysiology of tremor. Frontiers in Systems Neuroscience. 5: 49. PMID 21772815 DOI: 10.3389/Fnsys.2011.00049  0.703
2011 Collins LE, Paul NE, Abbas SF, Leser CE, Podurgiel SJ, Galtieri DJ, Chrobak JJ, Baqi Y, Müller CE, Salamone JD. Oral tremor induced by galantamine in rats: a model of the parkinsonian side effects of cholinomimetics used to treat Alzheimer's disease. Pharmacology, Biochemistry, and Behavior. 99: 414-22. PMID 21640750 DOI: 10.1016/J.Pbb.2011.05.026  0.358
2011 Randall PA, Nunes EJ, Janniere SL, Stopper CM, Farrar AM, Sager TN, Baqi Y, Hockemeyer J, Müller CE, Salamone JD. Stimulant effects of adenosine antagonists on operant behavior: differential actions of selective A2A and A1 antagonists. Psychopharmacology. 216: 173-86. PMID 21347642 DOI: 10.1007/S00213-011-2198-3  0.83
2011 Pereira M, Farrar AM, Hockemeyer J, Müller CE, Salamone JD, Morrell JI. Effect of the adenosine A2A receptor antagonist MSX-3 on motivational disruptions of maternal behavior induced by dopamine antagonism in the early postpartum rat. Psychopharmacology. 213: 69-79. PMID 20848086 DOI: 10.1007/S00213-010-2015-4  0.796
2010 Salamone JD. Preladenant, a novel adenosine A(2A) receptor antagonist for the potential treatment of parkinsonism and other disorders. Idrugs : the Investigational Drugs Journal. 13: 723-31. PMID 20878595  0.308
2010 Randall PA, Vemuri VK, Segovia KN, Torres EF, Hosmer S, Nunes EJ, Santerre JL, Makriyannis A, Salamone JD. The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behavior. Pharmacology, Biochemistry, and Behavior. 97: 179-84. PMID 20713079 DOI: 10.1016/J.Pbb.2010.07.021  0.813
2010 Nunes EJ, Randall PA, Santerre JL, Given AB, Sager TN, Correa M, Salamone JD. Differential effects of selective adenosine antagonists on the effort-related impairments induced by dopamine D1 and D2 antagonism. Neuroscience. 170: 268-80. PMID 20600675 DOI: 10.1016/J.Neuroscience.2010.05.068  0.843
2010 McLaughlin PJ, Winston KM, Swezey LA, Vemuri VK, Makriyannis A, Salamone JD. Detailed analysis of food-reinforced operant lever pressing distinguishes effects of a cannabinoid CB1 inverse agonist and dopamine D1 and D2 antagonists. Pharmacology, Biochemistry, and Behavior. 96: 75-81. PMID 20403373 DOI: 10.1016/J.Pbb.2010.04.009  0.685
2010 Sink KS, Segovia KN, Collins LE, Markus EJ, Vemuri VK, Makriyannis A, Salamone JD. The CB1 inverse agonist AM251, but not the CB1 antagonist AM4113, enhances retention of contextual fear conditioning in rats. Pharmacology, Biochemistry, and Behavior. 95: 479-84. PMID 20347865 DOI: 10.1016/J.Pbb.2010.03.011  0.809
2010 Collins LE, Galtieri DJ, Collins P, Jones SK, Port RG, Paul NE, Hockemeyer J, Müller CE, Salamone JD. Interactions between adenosine and dopamine receptor antagonists with different selectivity profiles: Effects on locomotor activity. Behavioural Brain Research. 211: 148-55. PMID 20211657 DOI: 10.1016/J.Bbr.2010.03.003  0.406
2010 Farrar AM, Segovia KN, Randall PA, Nunes EJ, Collins LE, Stopper CM, Port RG, Hockemeyer J, Müller CE, Correa M, Salamone JD. Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors. Neuroscience. 166: 1056-67. PMID 20096336 DOI: 10.1016/J.Neuroscience.2009.12.056  0.85
2010 Sink KS, Segovia KN, Sink J, Randall PA, Collins LE, Correa M, Markus EJ, Vemuri VK, Makriyannis A, Salamone JD. Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 112-22. PMID 20015619 DOI: 10.1016/J.Euroneuro.2009.11.002  0.842
2010 Collins LE, Galtieri DJ, Brennum LT, Sager TN, Hockemeyer J, Müller CE, Hinman JR, Chrobak JJ, Salamone JD. Oral tremor induced by the muscarinic agonist pilocarpine is suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX. Pharmacology, Biochemistry, and Behavior. 94: 561-9. PMID 19958787 DOI: 10.1016/J.Pbb.2009.11.011  0.407
2010 Salamone JD, Correa M, Farrar AM, Nunes EJ, Collins LE. Role of dopamine-adenosine interactions in the brain circuitry regulating effort-related decision making: Insights into pathological aspects of motivation Future Neurology. 5: 377-392. DOI: 10.2217/Fnl.10.19  0.777
2010 Vontell R, Segovia KN, Betz AJ, Mingote S, Goldring K, Cartun RW, Salamone JD. Immunocytochemistry studies of basal ganglia adenosine A2A receptors in rat and human tissue Journal of Histotechnology. 33: 41-47. DOI: 10.1179/His.2010.33.1.41  0.794
2010 Salamone JD. Involvement of Nucleus Accumbens Dopamine in Behavioral Activation and Effort-Related Functions Dopamine Handbook. DOI: 10.1093/acprof:oso/9780195373035.003.0020  0.334
2009 Salamone JD, Correa M, Farrar AM, Nunes EJ, Pardo M. Dopamine, behavioral economics, and effort. Frontiers in Behavioral Neuroscience. 3: 13. PMID 19826615 DOI: 10.3389/Neuro.08.013.2009  0.797
2009 Salamone JD, Correa M. Dopamine/adenosine interactions involved in effort-related aspects of food motivation. Appetite. 53: 422-5. PMID 19635514 DOI: 10.1016/j.appet.2009.07.018  0.525
2009 Sink KS, Segovia KN, Nunes EJ, Collins LE, Vemuri VK, Thakur G, Makriyannis A, Salamone JD. Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats. Psychopharmacology. 206: 223-32. PMID 19588124 DOI: 10.1007/S00213-009-1602-8  0.834
2009 Papanikolaou T, Amano T, Lennington J, Sink K, Farrar AM, Salamone J, Yang X, Conover JC. In-vitro analysis of Pitx3 in mesodiencephalic dopaminergic neuron maturation. The European Journal of Neuroscience. 29: 2264-75. PMID 19508691 DOI: 10.1111/J.1460-9568.2009.06784.X  0.701
2009 Betz AJ, Vontell R, Valenta J, Worden L, Sink KS, Font L, Correa M, Sager TN, Salamone JD. Effects of the adenosine A 2A antagonist KW 6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide. Neuroscience. 163: 97-108. PMID 19467297 DOI: 10.1016/j.neuroscience.2009.05.040  0.835
2009 Salamone JD, Farrar AM, Font L, Patel V, Schlar DE, Nunes EJ, Collins LE, Sager TN. Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism. Behavioural Brain Research. 201: 216-22. PMID 19428636 DOI: 10.1016/J.Bbr.2009.02.021  0.795
2009 Salamone JD. Dopamine, effort, and decision making: theoretical comment on Bardgett et al. (2009). Behavioral Neuroscience. 123: 463-7. PMID 19331471 DOI: 10.1037/a0015381  0.495
2009 Correa M, Arizzi-Lafrance MN, Salamone JD. Infusions of acetaldehyde into the arcuate nucleus of the hypothalamus induce motor activity in rats. Life Sciences. 84: 321-7. PMID 19146861 DOI: 10.1016/J.Lfs.2008.12.013  0.815
2009 Mott AM, Nunes EJ, Collins LE, Port RG, Sink KS, Hockemeyer J, Müller CE, Salamone JD. The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost/benefit procedure. Psychopharmacology. 204: 103-12. PMID 19132351 DOI: 10.1007/S00213-008-1441-Z  0.543
2009 Worden LT, Shahriari M, Farrar AM, Sink KS, Hockemeyer J, Müller CE, Salamone JD. The adenosine A2A antagonist MSX-3 reverses the effort-related effects of dopamine blockade: differential interaction with D1 and D2 family antagonists. Psychopharmacology. 203: 489-99. PMID 19048234 DOI: 10.1007/S00213-008-1396-0  0.805
2009 Sink KS, Vemuri VK, Wood J, Makriyannis A, Salamone JD. Oral bioavailability of the novel cannabinoid CB1 antagonist AM6527: effects on food-reinforced behavior and comparisons with AM4113. Pharmacology, Biochemistry, and Behavior. 91: 303-6. PMID 18703081 DOI: 10.1016/J.Pbb.2008.07.013  0.455
2008 Mingote S, Font L, Farrar AM, Vontell R, Worden LT, Stopper CM, Port RG, Sink KS, Bunce JG, Chrobak JJ, Salamone JD. Nucleus accumbens adenosine A2A receptors regulate exertion of effort by acting on the ventral striatopallidal pathway. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 9037-46. PMID 18768698 DOI: 10.1523/Jneurosci.1525-08.2008  0.835
2008 Hodge J, Bow JP, Plyler KS, Vemuri VK, Wisniecki A, Salamone JD, Makriyannis A, McLaughlin PJ. The cannabinoid CB1 receptor inverse agonist AM 251 and antagonist AM 4113 produce similar effects on the behavioral satiety sequence in rats. Behavioural Brain Research. 193: 298-305. PMID 18602425 DOI: 10.1016/J.Bbr.2008.06.010  0.842
2008 Salamone JD, Ishiwari K, Betz AJ, Farrar AM, Mingote SM, Font L, Hockemeyer J, Müller CE, Correa M. Dopamine/adenosine interactions related to locomotion and tremor in animal models: possible relevance to parkinsonism. Parkinsonism & Related Disorders. 14: S130-4. PMID 18585081 DOI: 10.1016/J.Parkreldis.2008.04.017  0.845
2008 Vanover KE, Betz AJ, Weber SM, Bibbiani F, Kielaite A, Weiner DM, Davis RE, Chase TN, Salamone JD. A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model. Pharmacology, Biochemistry, and Behavior. 90: 540-4. PMID 18534670 DOI: 10.1016/J.Pbb.2008.04.010  0.771
2008 Salamone JD, Betz AJ, Ishiwari K, Felsted J, Madson L, Mirante B, Clark K, Font L, Korbey S, Sager TN, Hockemeyer J, Muller CE. Tremorolytic effects of adenosine A2A antagonists: implications for parkinsonism. Frontiers in Bioscience : a Journal and Virtual Library. 13: 3594-605. PMID 18508458 DOI: 10.2741/2952  0.843
2008 Font L, Mingote S, Farrar AM, Pereira M, Worden L, Stopper C, Port RG, Salamone JD. Intra-accumbens injections of the adenosine A2A agonist CGS 21680 affect effort-related choice behavior in rats. Psychopharmacology. 199: 515-26. PMID 18491078 DOI: 10.1007/S00213-008-1174-Z  0.859
2008 McLaughlin PJ, Chuck TL, Arizzi-LaFrance MN, Salamone JD, Correa M. Central vs. peripheral administration of ethanol, acetaldehyde and acetate in rats: effects on lever pressing and response initiation. Pharmacology, Biochemistry, and Behavior. 89: 304-13. PMID 18294679 DOI: 10.1016/J.Pbb.2008.01.002  0.802
2008 Mingote S, Pereira M, Farrar AM, McLaughlin PJ, Salamone JD. Systemic administration of the adenosine A(2A) agonist CGS 21680 induces sedation at doses that suppress lever pressing and food intake. Pharmacology, Biochemistry, and Behavior. 89: 345-51. PMID 18281083 DOI: 10.1016/J.Pbb.2008.01.006  0.834
2008 Farrar AM, Font L, Pereira M, Mingote S, Bunce JG, Chrobak JJ, Salamone JD. Forebrain circuitry involved in effort-related choice: Injections of the GABAA agonist muscimol into ventral pallidum alter response allocation in food-seeking behavior. Neuroscience. 152: 321-30. PMID 18272291 DOI: 10.1016/J.Neuroscience.2007.12.034  0.851
2008 Papanikolaou T, Lennington JB, Betz A, Figueiredo C, Salamone JD, Conover JC. In vitro generation of dopaminergic neurons from adult subventricular zone neural progenitor cells. Stem Cells and Development. 17: 157-72. PMID 18248323 DOI: 10.1089/Scd.2007.0090  0.706
2008 Sink KS, Vemuri VK, Olszewska T, Makriyannis A, Salamone JD. Cannabinoid CB1 antagonists and dopamine antagonists produce different effects on a task involving response allocation and effort-related choice in food-seeking behavior. Psychopharmacology. 196: 565-74. PMID 18004546 DOI: 10.1007/S00213-007-0988-4  0.559
2008 Sink KS, McLaughlin PJ, Wood JA, Brown C, Fan P, Vemuri VK, Peng Y, Pang Y, Olszewska T, Olzewska T, Thakur GA, Makriyannis A, Parker LA, Salamone JD. The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 946-55. PMID 17581535 DOI: 10.1038/Sj.Npp.1301476  0.663
2008 Sink KS, McLaughlin PJ, Wood JAT, Brown C, Fan P, Vemuri VK, Pang Y, Olzewska T, Thakur GA, Makriyannis A, Parker LA, Salamone JD. The novel cannabinoid CB1 receptor neutral antagonist Am4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats (Neuropsychopharmacology (2008) 33, (946-955) DOI: 10.1038/sj.npp.1301476) Neuropsychopharmacology. 33: 1776. DOI: 10.1038/npp.2008.49  0.597
2007 Betz AJ, McLaughlin PJ, Burgos M, Weber SM, Salamone JD. The muscarinic receptor antagonist tropicamide suppresses tremulous jaw movements in a rodent model of parkinsonian tremor: possible role of M4 receptors. Psychopharmacology. 194: 347-59. PMID 17594079 DOI: 10.1007/S00213-007-0844-6  0.803
2007 Salamone JD, McLaughlin PJ, Sink K, Makriyannis A, Parker LA. Cannabinoid CB1 receptor inverse agonists and neutral antagonists: effects on food intake, food-reinforced behavior and food aversions. Physiology & Behavior. 91: 383-8. PMID 17521686 DOI: 10.1016/J.Physbeh.2007.04.013  0.652
2007 Salamone JD. Functions of mesolimbic dopamine: changing concepts and shifting paradigms. Psychopharmacology. 191: 389. PMID 17334798 DOI: 10.1007/s00213-006-0623-9  0.363
2007 Salamone JD, Correa M, Farrar A, Mingote SM. Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology. 191: 461-82. PMID 17225164 DOI: 10.1007/S00213-006-0668-9  0.843
2007 Ishiwari K, Madson LJ, Farrar AM, Mingote SM, Valenta JP, DiGianvittorio MD, Frank LE, Correa M, Hockemeyer J, Müller C, Salamone JD. Injections of the selective adenosine A2A antagonist MSX-3 into the nucleus accumbens core attenuate the locomotor suppression induced by haloperidol in rats. Behavioural Brain Research. 178: 190-9. PMID 17223207 DOI: 10.1016/J.Bbr.2006.12.020  0.845
2007 Farrar AM, Pereira M, Velasco F, Hockemeyer J, Müller CE, Salamone JD. Adenosine A(2A) receptor antagonism reverses the effects of dopamine receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowing. Psychopharmacology. 191: 579-86. PMID 17072593 DOI: 10.1007/S00213-006-0554-5  0.815
2006 Dishman RK, Berthoud HR, Booth FW, Cotman CW, Edgerton VR, Fleshner MR, Gandevia SC, Gomez-Pinilla F, Greenwood BN, Hillman CH, Kramer AF, Levin BE, Moran TH, Russo-Neustadt AA, Salamone JD, et al. Neurobiology of exercise. Obesity (Silver Spring, Md.). 14: 345-56. PMID 16648603 DOI: 10.1038/Oby.2006.46  0.506
2006 McLaughlin PJ, Qian L, Wood JT, Wisniecki A, Winston KM, Swezey LA, Ishiwari K, Betz AJ, Pandarinathan L, Xu W, Makriyannis A, Salamone JD. Suppression of food intake and food-reinforced behavior produced by the novel CB1 receptor antagonist/inverse agonist AM 1387. Pharmacology, Biochemistry, and Behavior. 83: 396-402. PMID 16616951 DOI: 10.1016/J.Pbb.2006.02.022  0.822
2006 Chuck TL, McLaughlin PJ, Arizzi-LaFrance MN, Salamone JD, Correa M. Comparison between multiple behavioral effects of peripheral ethanol administration in rats: sedation, ataxia, and bradykinesia. Life Sciences. 79: 154-61. PMID 16487981 DOI: 10.1016/J.Lfs.2005.12.045  0.814
2006 Arizzi-LaFrance MN, Correa M, Aragon CM, Salamone JD. Motor stimulant effects of ethanol injected into the substantia nigra pars reticulata: importance of catalase-mediated metabolism and the role of acetaldehyde. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 997-1008. PMID 16123765 DOI: 10.1038/Sj.Npp.1300849  0.797
2006 Salamone JD, Correa M, Mingote SM, Weber SM, Farrar AM. Nucleus accumbens dopamine and the forebrain circuitry involved in behavioral activation and effort-related decision making: Implications for understanding anergia and psychomotor slowing in depression Current Psychiatry Reviews. 2: 267-280. DOI: 10.2174/157340006776875914  0.842
2006 Brown C, Salamone JD, Sink K, McLaughlin PJ. WITHDRAWN: Effects of cannabinoid antagonists on intake of different foods Appetite. DOI: 10.1016/J.Appet.2006.03.285  0.592
2005 McLaughlin PJ, Brown CM, Winston KM, Thakur G, Lu D, Makriyannis A, Salamone JD. The novel cannabinoid agonist AM 411 produces a biphasic effect on accuracy in a visual target detection task in rats. Behavioural Pharmacology. 16: 477-86. PMID 16148454 DOI: 10.1097/00008877-200509000-00022  0.561
2005 McLaughlin PJ, Winston KM, Limebeer CL, Parker LA, Makriyannis A, Salamone JD. The cannabinoid CB1 antagonist AM 251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats. Psychopharmacology. 180: 286-93. PMID 15948012 DOI: 10.1007/S00213-005-2171-0  0.635
2005 McLaughlin PJ, Lu D, Winston KM, Thakur G, Swezey LA, Makriyannis A, Salamone JD. Behavioral effects of the novel cannabinoid full agonist AM 411. Pharmacology, Biochemistry, and Behavior. 81: 78-88. PMID 15894067 DOI: 10.1016/J.Pbb.2005.02.005  0.668
2005 Mingote S, Weber SM, Ishiwari K, Correa M, Salamone JD. Ratio and time requirements on operant schedules: effort-related effects of nucleus accumbens dopamine depletions. The European Journal of Neuroscience. 21: 1749-57. PMID 15845103 DOI: 10.1111/J.1460-9568.2005.03972.X  0.828
2005 Quertemont E, Grant KA, Correa M, Arizzi MN, Salamone JD, Tambour S, Aragon CM, McBride WJ, Rodd ZA, Goldstein A, Zaffaroni A, Li TK, Pisano M, Diana M. The role of acetaldehyde in the central effects of ethanol. Alcoholism, Clinical and Experimental Research. 29: 221-34. PMID 15714045 DOI: 10.1097/01.Alc.0000156185.39073.D2  0.391
2005 Ishiwari K, Betz A, Weber S, Felsted J, Salamone JD. Validation of the tremulous jaw movement model for assessment of the motor effects of typical and atypical antipychotics: effects of pimozide (Orap) in rats. Pharmacology, Biochemistry, and Behavior. 80: 351-62. PMID 15680188 DOI: 10.1016/J.Pbb.2004.12.006  0.83
2005 Salamone JD, Correa M, Mingote SM, Weber SM. Beyond the reward hypothesis: alternative functions of nucleus accumbens dopamine. Current Opinion in Pharmacology. 5: 34-41. PMID 15661623 DOI: 10.1016/j.coph.2004.09.004  0.758
2005 Betz A, Ishiwari K, Wisniecki A, Huyn N, Salamone JD. Quetiapine (Seroquel) shows a pattern of behavioral effects similar to the atypical antipsychotics clozapine and olanzapine: studies with tremulous jaw movements in rats. Psychopharmacology. 179: 383-92. PMID 15619122 DOI: 10.1007/S00213-004-2046-9  0.826
2005 Salamone JD, Carlson BB, Rios C, Lentini E, Correa M, Wisniecki A, Betz A. Dopamine agonists suppress cholinomimetic-induced tremulous jaw movements in an animal model of Parkinsonism: tremorolytic effects of pergolide, ropinirole and CY 208-243. Behavioural Brain Research. 156: 173-9. PMID 15582103 DOI: 10.1016/J.Bbr.2004.05.019  0.833
2005 Salamone J, Betz A, McLaughlin P, Burgos M, Ishiwari K, Weber S, Felsted J, Brown C. B15 AN ANIMAL MODEL FOR ASSESSING THE POTENTIAL ANTIPARKINSONIAN CHARACTERISTICS OF M4 MUSCARINIC ANTAGONISTS: EFFECTS OF THE PARTIALLY SELECTIVE M4 ANTAGONIST TROPICAMIDE Behavioural Pharmacology. 16: S70. DOI: 10.1097/00008877-200509001-00220  0.784
2005 Correa M, Salamone J, Aragon C. O4 CENTRAL AND PERIPHERAL EFFECTS OF ETHANOL AND ACETALDEHYDE ON MEASURES OF ANXIETY IN RATS Behavioural Pharmacology. 16: S19. DOI: 10.1097/00008877-200509001-00061  0.322
2004 Ishiwari K, Mingote S, Correa M, Trevitt JT, Carlson BB, Salamone JD. The GABA uptake inhibitor beta-alanine reduces pilocarpine-induced tremor and increases extracellular GABA in substantia nigra pars reticulata as measured by microdialysis. Journal of Neuroscience Methods. 140: 39-46. PMID 15589332 DOI: 10.1016/J.Jneumeth.2004.03.030  0.801
2004 Ishiwari K, Weber SM, Mingote S, Correa M, Salamone JD. Accumbens dopamine and the regulation of effort in food-seeking behavior: modulation of work output by different ratio or force requirements. Behavioural Brain Research. 151: 83-91. PMID 15084424 DOI: 10.1016/J.Bbr.2003.08.007  0.831
2004 Correa M, Wisniecki A, Betz A, Dobson DR, O'Neill MF, O'Neill MJ, Salamone JD. The adenosine A2A antagonist KF17837 reverses the locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonism. Behavioural Brain Research. 148: 47-54. PMID 14684247 DOI: 10.1016/S0166-4328(03)00178-5  0.854
2004 Arizzi MN, Cervone KM, Aberman JE, Betz A, Liu Q, Lin S, Makriyannis A, Salamone JD. Behavioral effects of inhibition of cannabinoid metabolism: The amidase inhibitor AM374 enhances the suppression of lever pressing produced by exogenously administered anandamide. Life Sciences. 74: 1001-11. PMID 14672756 DOI: 10.1016/J.Lfs.2003.07.024  0.77
2003 Correa M, Arizzi MN, Betz A, Mingote S, Salamone JD. Open field locomotor effects in rats after intraventricular injections of ethanol and the ethanol metabolites acetaldehyde and acetate. Brain Research Bulletin. 62: 197-202. PMID 14698353 DOI: 10.1016/j.brainresbull.2003.09.013  0.816
2003 McLaughlin PJ, Winston K, Swezey L, Wisniecki A, Aberman J, Tardif DJ, Betz AJ, Ishiwari K, Makriyannis A, Salamone JD. The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats. Behavioural Pharmacology. 14: 583-8. PMID 14665975 DOI: 10.1097/00008877-200312000-00002  0.826
2003 Arizzi MN, Correa M, Betz AJ, Wisniecki A, Salamone JD. Behavioral effects of intraventricular injections of low doses of ethanol, acetaldehyde, and acetate in rats: studies with low and high rate operant schedules. Behavioural Brain Research. 147: 203-10. PMID 14659586 DOI: 10.1016/S0166-4328(03)00158-X  0.811
2003 Correa M, Arizzi MN, Betz A, Mingote S, Salamone JD. Locomotor stimulant effects of intraventricular injections of low doses of ethanol in rats: acute and repeated administration. Psychopharmacology. 170: 368-75. PMID 12955297 DOI: 10.1007/s00213-003-1557-0  0.813
2003 Carlson BB, Behrstock S, Tobin AJ, Salamone JD. Brain implantations of engineered GABA-releasing cells suppress tremor in an animal model of Parkinsonism. Neuroscience. 119: 927-32. PMID 12831853 DOI: 10.1016/S0306-4522(03)00218-5  0.348
2003 Wisniecki A, Correa M, Arizzi MN, Ishiwari K, Salamone JD. Motor effects of GABA(A) antagonism in globus pallidus: studies of locomotion and tremulous jaw movements in rats. Psychopharmacology. 170: 140-9. PMID 12827348 DOI: 10.1007/S00213-003-1521-Z  0.83
2003 Correa M, Mingote S, Betz A, Wisniecki A, Salamone JD. Substantia nigra pars reticulata GABA is involved in the regulation of operant lever pressing: pharmacological and microdialysis studies. Neuroscience. 119: 759-66. PMID 12809696 DOI: 10.1016/S0306-4522(03)00117-9  0.8
2003 Salamone JD, Correa M, Mingote S, Weber SM. Nucleus accumbens dopamine and the regulation of effort in food-seeking behavior: implications for studies of natural motivation, psychiatry, and drug abuse. The Journal of Pharmacology and Experimental Therapeutics. 305: 1-8. PMID 12649346 DOI: 10.1124/jpet.102.035063  0.769
2003 Carlson BB, Wisniecki A, Salamone JD. Local injections of the 5-hydroxytryptamine antagonist mianserin into substantia nigra pars reticulata block tremulous jaw movements in rats: studies with a putative model of Parkinsonian tremor. Psychopharmacology. 165: 229-37. PMID 12420151 DOI: 10.1007/S00213-002-1247-3  0.835
2002 Correa M, Carlson BB, Wisniecki A, Salamone JD. Nucleus accumbens dopamine and work requirements on interval schedules. Behavioural Brain Research. 137: 179-87. PMID 12445723 DOI: 10.1016/S0166-4328(02)00292-9  0.838
2002 Salamone JD, Correa M. Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine. Behavioural Brain Research. 137: 3-25. PMID 12445713 DOI: 10.1016/S0166-4328(02)00282-6  0.419
2002 Salamone JD. Functional significance of nucleus accumbens dopamine: behavior, pharmacology and neurochemistry. Behavioural Brain Research. 137: 1. PMID 12445712 DOI: 10.1016/S0166-4328(02)00281-4  0.441
2002 Salamone JD, Arizzi MN, Sandoval MD, Cervone KM, Aberman JE. Dopamine antagonists alter response allocation but do not suppress appetite for food in rats: contrast between the effects of SKF 83566, raclopride, and fenfluramine on a concurrent choice task. Psychopharmacology. 160: 371-80. PMID 11919664 DOI: 10.1007/s00213-001-0994-x  0.53
2002 Trevitt T, Carlson B, Correa M, Keene A, Morales M, Salamone JD. Interactions between dopamine D1 receptors and gamma-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: neurochemical and behavioral studies. Psychopharmacology. 159: 229-37. PMID 11862355 DOI: 10.1007/s002130100908  0.418
2001 Salamone JD, Wisniecki A, Carlson BB, Correa M. Nucleus accumbens dopamine depletions make animals highly sensitive to high fixed ratio requirements but do not impair primary food reinforcement. Neuroscience. 105: 863-70. PMID 11530224 DOI: 10.1016/S0306-4522(01)00249-4  0.844
2001 Nowend KL, Arizzi M, Carlson BB, Salamone JD. D1 or D2 antagonism in nucleus accumbens core or dorsomedial shell suppresses lever pressing for food but leads to compensatory increases in chow consumption. Pharmacology, Biochemistry, and Behavior. 69: 373-82. PMID 11509194 DOI: 10.1016/S0091-3057(01)00524-X  0.512
2001 Trevitt JT, Carlson BB, Nowend K, Salamone JD. Substantia nigra pars reticulata is a highly potent site of action for the behavioral effects of the D1 antagonist SCH 23390 in the rat. Psychopharmacology. 156: 32-41. PMID 11465631 DOI: 10.1007/s002130100708  0.374
2001 Salamone JD, Correa M, Carlson BB, Wisniecki A, Mayorga AJ, Nisenbaum E, Nisenbaum L, Felder C. Neostriatal muscarinic receptor subtypes involved in the generation of tremulous jaw movements in rodents implications for cholinergic involvement in parkinsonism. Life Sciences. 68: 2579-84. PMID 11392629 DOI: 10.1016/S0024-3205(01)01055-4  0.817
2000 Carlson BB, Trevitt JT, Salamone JD. Effects of H1 antagonists on cholinomimetic-induced tremulous jaw movements: studies of diphenhydramine, doxepin, and mepyramine. Pharmacology, Biochemistry, and Behavior. 65: 683-9. PMID 10764923 DOI: 10.1016/S0091-3057(99)00242-7  0.432
1999 Hamill S, Trevitt JT, Nowend KL, Carlson BB, Salamone JD. Nucleus accumbens dopamine depletions and time-constrained progressive ratio performance: effects of different ratio requirements. Pharmacology, Biochemistry, and Behavior. 64: 21-7. PMID 10494993 DOI: 10.1016/S0091-3057(99)00092-1  0.379
1999 Trevitt JT, Carlson BB, Salamone JD. Behavioral assessment of atypical antipsychotics in rats: studies of the effects of olanzapine (Zyprexa). Psychopharmacology. 145: 309-16. PMID 10494580 DOI: 10.1007/s002130051063  0.467
1999 Aberman JE, Salamone JD. Nucleus accumbens dopamine depletions make rats more sensitive to high ratio requirements but do not impair primary food reinforcement. Neuroscience. 92: 545-52. PMID 10408603 DOI: 10.1016/S0306-4522(99)00004-4  0.49
1999 Cousins MS, Trevitt J, Atherton A, Salamone JD. Different behavioral functions of dopamine in the nucleus accumbens and ventrolateral striatum: a microdialysis and behavioral investigation. Neuroscience. 91: 925-34. PMID 10391471 DOI: 10.1016/S0306-4522(98)00617-4  0.483
1999 Mayorga AJ, Gianutsos G, Salamone JD. Effects of striatal injections of 8-bromo-cyclic-AMP on pilocarpine-induced tremulous jaw movements in rats. Brain Research. 829: 180-4. PMID 10350545 DOI: 10.1016/S0006-8993(99)01352-9  0.441
1999 Mayorga AJ, Trevitt JT, Conlan A, Gianutsos G, Salamone JD. Striatal and nigral D1 mechanisms involved in the antiparkinsonian effects of SKF 82958 (APB): studies of tremulous jaw movements in rats. Psychopharmacology. 143: 72-81. PMID 10227082 DOI: 10.1007/s002130050921  0.525
1999 Cousins MS, Finn M, Trevitt J, Carriero DL, Conlan A, Salamone JD. The role of ventrolateral striatal acetylcholine in the production of tacrine-induced jaw movements. Pharmacology, Biochemistry, and Behavior. 62: 439-47. PMID 10080235 DOI: 10.1016/S0091-3057(98)00214-7  0.43
1999 Mayorga AJ, Cousins MS, Trevitt JT, Conlan A, Gianutsos G, Salamone JD. Characterization of the muscarinic receptor subtype mediating pilocarpine-induced tremulous jaw movements in rats. European Journal of Pharmacology. 364: 7-11. PMID 9920179 DOI: 10.1016/S0014-2999(98)00811-5  0.392
1999 Salamone JD, Aberman JE, Sokolowski JD, Cousins MS. Nucleus accumbens dopamine and rate of responding: Neurochemical and behavioral studies Psychobiology. 27: 236-247. DOI: 10.3758/Bf03332117  0.492
1999 Salamone J. INTERFERENCE WITH ACCUMBENS DOPAMINE TRANSMISSION MAKES RATS MORE SENSITIVE TO WORK REQUIREMENTS BUT DOES NOT IMPAIR PRIMARY FOOD REINFORCEMENT Behavioural Pharmacology. 10: S79. DOI: 10.1097/00008877-199908001-00202  0.455
1998 Salamone JD, Mayorga AJ, Trevitt JT, Cousins MS, Conlan A, Nawab A. Tremulous jaw movements in rats: a model of parkinsonian tremor. Progress in Neurobiology. 56: 591-611. PMID 9871939 DOI: 10.1016/S0301-0082(98)00053-7  0.412
1998 Aberman JE, Ward SJ, Salamone JD. Effects of dopamine antagonists and accumbens dopamine depletions on time-constrained progressive-ratio performance. Pharmacology, Biochemistry, and Behavior. 61: 341-8. PMID 9802826 DOI: 10.1016/S0091-3057(98)00112-9  0.693
1998 Sokolowski JD, Conlan AN, Salamone JD. A microdialysis study of nucleus accumbens core and shell dopamine during operant responding in the rat. Neuroscience. 86: 1001-9. PMID 9692735 DOI: 10.1016/S0306-4522(98)00066-9  0.482
1998 Cousins MS, Atherton A, Salamone JD. Behavioral and electromyographic characterization of the local frequency of tacrine-induced tremulous jaw movements. Physiology & Behavior. 64: 153-8. PMID 9662079 DOI: 10.1016/S0031-9384(98)00021-3  0.304
1998 Liu YC, Sachs BD, Salamone JD. Sexual behavior in male rats after radiofrequency or dopamine-depleting lesions in nucleus accumbens. Pharmacology, Biochemistry, and Behavior. 60: 585-92. PMID 9632244 DOI: 10.1016/S0091-3057(98)00022-7  0.375
1998 Trevitt J, Atherton A, Aberman J, Salamone JD. Effects of subchronic administration of clozapine, thioridazine and haloperidol on tests related to extrapyramidal motor function in the rat. Psychopharmacology. 137: 61-6. PMID 9631957 DOI: 10.1007/s002130050593  0.449
1998 Carriero D, Aberman J, Lin SY, Hill A, Makriyannis A, Salamone JD. A detailed characterization of the effects of four cannabinoid agonists on operant lever pressing. Psychopharmacology. 137: 147-56. PMID 9630001 DOI: 10.1007/S002130050604  0.423
1998 Sokolowski JD, Salamone JD. The role of accumbens dopamine in lever pressing and response allocation: effects of 6-OHDA injected into core and dorsomedial shell. Pharmacology, Biochemistry, and Behavior. 59: 557-66. PMID 9512057 DOI: 10.1016/S0091-3057(97)00544-3  0.407
1997 Liu YC, Salamone JD, Sachs BD. Impaired sexual response after lesions of the paraventricular nucleus of the hypothalamus in male rats. Behavioral Neuroscience. 111: 1361-7. PMID 9438804 DOI: 10.1037/0735-7044.111.6.1361  0.317
1997 Carriero DL, Outslay G, Mayorga AJ, Aberman J, Gianutsos G, Salamone JD. Motor dysfunction produced by tacrine administration in rats. Pharmacology, Biochemistry, and Behavior. 58: 851-8. PMID 9408186 DOI: 10.1016/S0091-3057(97)98986-3  0.436
1997 Finn M, Mayorga AJ, Conlan A, Salamone JD. Involvement of pallidal and nigral GABA mechanisms in the generation of tremulous jaw movements in rats. Neuroscience. 80: 535-44. PMID 9284355 DOI: 10.1016/S0306-4522(97)00087-0  0.429
1997 Trevitt JT, Lyons M, Aberman J, Carriero D, Finn M, Salamone JD. Effects of clozapine, thioridazine, risperidone and haloperidol on behavioral tests related to extrapyramidal motor function. Psychopharmacology. 132: 74-81. PMID 9272762 DOI: 10.1007/s002130050322  0.463
1997 Liu YC, Salamone JD, Sachs BD. Lesions in medial preoptic area and bed nucleus of stria terminalis: differential effects on copulatory behavior and noncontact erection in male rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 5245-53. PMID 9185562 DOI: 10.1523/Jneurosci.17-13-05245.1997  0.3
1997 Salamone JD, Cousins MS, Snyder BJ. Behavioral functions of nucleus accumbens dopamine: empirical and conceptual problems with the anhedonia hypothesis. Neuroscience and Biobehavioral Reviews. 21: 341-59. PMID 9168269 DOI: 10.1016/S0149-7634(96)00017-6  0.401
1997 Finn M, Jassen A, Baskin P, Salamone JD. Tremulous characteristics of the vacuous jaw movements induced by pilocarpine and ventrolateral striatal dopamine depletions. Pharmacology, Biochemistry, and Behavior. 57: 243-9. PMID 9164578 DOI: 10.1016/S0091-3057(96)00385-1  0.439
1997 Lindner MD, Plone MA, Francis JM, Blaney TJ, Salamone JD, Emerich DF. Rats with partial striatal dopamine depletions exhibit robust and long-lasting behavioral deficits in a simple fixed-ratio bar-pressing task. Behavioural Brain Research. 86: 25-40. PMID 9105579 DOI: 10.1016/S0166-4328(96)02240-1  0.468
1997 Cousins MS, Carriero DL, Salamone JD. Tremulous jaw movements induced by the acetylcholinesterase inhibitor tacrine: effects of antiparkinsonian drugs. European Journal of Pharmacology. 322: 137-45. PMID 9098680 DOI: 10.1016/S0014-2999(97)00008-3  0.507
1997 Mayorga AJ, Carriero DL, Cousins MS, Gianutsos G, Salamone JD. Tremulous jaw movements produced by acute tacrine administration: possible relation to parkinsonian side effects. Pharmacology, Biochemistry, and Behavior. 56: 273-9. PMID 9050085 DOI: 10.1016/S0091-3057(96)00225-0  0.418
1996 Cousins MS, Salamone JD. Skilled motor deficits in rats induced by ventrolateral striatal dopamine depletions: behavioral and pharmacological characterization. Brain Research. 732: 186-94. PMID 8891283 DOI: 10.1016/0006-8993(96)00519-7  0.46
1996 Cousins MS, Atherton A, Turner L, Salamone JD. Nucleus accumbens dopamine depletions alter relative response allocation in a T-maze cost/benefit task. Behavioural Brain Research. 74: 189-97. PMID 8851929 DOI: 10.1016/0166-4328(95)00151-4  0.391
1996 Salamone J, Baskin P. Vacuous jaw movements induced by acute reserpine and low-dose apomorphine: possible model of parkinsonian tremor. Pharmacology, Biochemistry, and Behavior. 53: 179-83. PMID 8848448 DOI: 10.1016/0091-3057(95)00164-6  0.413
1996 Cousins MS, Salamone JD. Involvement of ventrolateral striatal dopamine in movement initiation and execution: a microdialysis and behavioral investigation. Neuroscience. 70: 849-59. PMID 8848171 DOI: 10.1016/0306-4522(95)00407-6  0.488
1996 Salamone JD, Cousins MS, Maio C, Champion M, Turski T, Kovach J. Different behavioral effects of haloperidol, clozapine and thioridazine in a concurrent lever pressing and feeding procedure. Psychopharmacology. 125: 105-12. PMID 8783383 DOI: 10.1007/BF02249408  0.491
1996 Chesler EJ, Salamone JD. Effects of acute and repeated clozapine injections on cholinomimetic-induced vacuous jaw movements. Pharmacology, Biochemistry, and Behavior. 54: 619-24. PMID 8743638 DOI: 10.1016/0091-3057(95)02280-5  0.635
1996 Salamone JD. The behavioral neurochemistry of motivation: methodological and conceptual issues in studies of the dynamic activity of nucleus accumbens dopamine. Journal of Neuroscience Methods. 64: 137-49. PMID 8699874 DOI: 10.1016/0165-0270(95)00125-5  0.49
1995 Salamone JD, Kurth P, McCullough LD, Sokolowski JD. The effects of nucleus accumbens dopamine depletions on continuously reinforced operant responding: contrasts with the effects of extinction. Pharmacology, Biochemistry, and Behavior. 50: 437-43. PMID 7617683 DOI: 10.1016/0091-3057(94)00294-S  0.634
1994 Baskin P, Salamone J. Vacuous jaw movements in rats induced by acute reserpine administration: interactions with different doses of apomorphine. Pharmacology, Biochemistry, and Behavior. 46: 793-7. PMID 8309957 DOI: 10.1016/0091-3057(93)90203-6  0.45
1994 Steinpreis RE, Sokolowski JD, Papanikolaou A, Salamone JD. The effects of haloperidol and clozapine on PCP- and amphetamine-induced suppression of social behavior in the rat. Pharmacology, Biochemistry, and Behavior. 47: 579-85. PMID 8208777 DOI: 10.1016/0091-3057(94)90162-7  0.762
1994 Salamone JD. The involvement of nucleus accumbens dopamine in appetitive and aversive motivation. Behavioural Brain Research. 61: 117-33. PMID 8037860 DOI: 10.1016/0166-4328(94)90153-8  0.353
1994 Sokolowski JD, Salamone JD. Effects of dopamine depletions in the medial prefrontal cortex on DRL performance and motor activity in the rat. Brain Research. 642: 20-8. PMID 8032881 DOI: 10.1016/0006-8993(94)90901-6  0.481
1994 Sokolowski JD, McCullough LD, Salamone JD. Effects of dopamine depletions in the medial prefrontal cortex on active avoidance and escape in the rat. Brain Research. 651: 293-9. PMID 7922578 DOI: 10.1016/0006-8993(94)90709-9  0.617
1994 Baskin PP, Gianutsos G, Salamone JD. Repeated scopolamine injections sensitize rats to pilocarpine-induced vacuous jaw movements and enhance striatal muscarinic receptor binding. Pharmacology, Biochemistry, and Behavior. 49: 437-42. PMID 7824562 DOI: 10.1016/0091-3057(94)90446-4  0.482
1994 Cousins MS, Salamone JD. Nucleus accumbens dopamine depletions in rats affect relative response allocation in a novel cost/benefit procedure. Pharmacology, Biochemistry, and Behavior. 49: 85-91. PMID 7816895 DOI: 10.1016/0091-3057(94)90460-X  0.407
1994 Salamone JD, Cousins MS, McCullough LD, Carriero DL, Berkowitz RJ. Nucleus accumbens dopamine release increases during instrumental lever pressing for food but not free food consumption. Pharmacology, Biochemistry, and Behavior. 49: 25-31. PMID 7816884 DOI: 10.1016/0091-3057(94)90452-9  0.583
1994 Salamone JD, Cousins MS, Bucher S. Anhedonia or anergia? Effects of haloperidol and nucleus accumbens dopamine depletion on instrumental response selection in a T-maze cost/benefit procedure. Behavioural Brain Research. 65: 221-9. PMID 7718155 DOI: 10.1016/0166-4328(94)90108-2  0.347
1994 Cousins MS, Wei W, Salamone JD. Pharmacological characterization of performance on a concurrent lever pressing/feeding choice procedure: effects of dopamine antagonist, cholinomimetic, sedative and stimulant drugs. Psychopharmacology. 116: 529-37. PMID 7701059 DOI: 10.1007/BF02247489  0.548
1993 Salamone JD, Mahan K, Rogers S. Ventrolateral striatal dopamine depletions impair feeding and food handling in rats. Pharmacology, Biochemistry, and Behavior. 44: 605-10. PMID 8451265 DOI: 10.1016/0091-3057(93)90174-R  0.496
1993 McCullough LD, Sokolowski JD, Salamone JD. A neurochemical and behavioral investigation of the involvement of nucleus accumbens dopamine in instrumental avoidance. Neuroscience. 52: 919-25. PMID 8450978 DOI: 10.1016/0306-4522(93)90538-Q  0.583
1993 Steinpreis RE, Salamone JD. The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microdialysis and behavioral study. Brain Research. 612: 263-70. PMID 8330204 DOI: 10.1016/0006-8993(93)91671-E  0.804
1993 Salamone JD, Kurth PA, McCullough LD, Sokolowski JD, Cousins MS. The role of brain dopamine in response initiation: effects of haloperidol and regionally specific dopamine depletions on the local rate of instrumental responding. Brain Research. 628: 218-26. PMID 8313150 DOI: 10.1016/0006-8993(93)90958-P  0.636
1993 Cousins MS, Sokolowski JD, Salamone JD. Different effects of nucleus accumbens and ventrolateral striatal dopamine depletions on instrumental response selection in the rat. Pharmacology, Biochemistry, and Behavior. 46: 943-51. PMID 8309975 DOI: 10.1016/0091-3057(93)90226-J  0.438
1993 McCullough LD, Cousins MS, Salamone JD. The role of nucleus accumbens dopamine in responding on a continuous reinforcement operant schedule: a neurochemical and behavioral study. Pharmacology, Biochemistry, and Behavior. 46: 581-6. PMID 8278435 DOI: 10.1016/0091-3057(93)90547-7  0.601
1993 Steinpreis RE, Salamone JD. Effects of acute haloperidol and reserpine administration on vacuous jaw movements in three different age groups of rats. Pharmacology, Biochemistry, and Behavior. 46: 405-9. PMID 8265695 DOI: 10.1016/0091-3057(93)90371-Y  0.733
1993 Steinpreis RE, Baskin P, Salamone JD. Vacuous jaw movements induced by sub-chronic administration of haloperidol: interactions with scopolamine. Psychopharmacology. 111: 99-105. PMID 7870941 DOI: 10.1007/BF02257414  0.759
1992 Salamone JD. Complex motor and sensorimotor functions of striatal and accumbens dopamine: involvement in instrumental behavior processes. Psychopharmacology. 107: 160-74. PMID 1615120 DOI: 10.1007/BF02245133  0.441
1992 McCullough LD, Salamone JD. Increases in extracellular dopamine levels and locomotor activity after direct infusion of phencyclidine into the nucleus accumbens. Brain Research. 577: 1-9. PMID 1521135 DOI: 10.1016/0006-8993(92)90530-M  0.602
1992 McCullough LD, Salamone JD. Involvement of nucleus accumbens dopamine in the motor activity induced by periodic food presentation: a microdialysis and behavioral study. Brain Research. 592: 29-36. PMID 1450917 DOI: 10.1016/0006-8993(92)91654-W  0.598
1992 McCullough LD, Salamone JD. Anxiogenic drugs beta-CCE and FG 7142 increase extracellular dopamine levels in nucleus accumbens. Psychopharmacology. 109: 379-82. PMID 1365640 DOI: 10.1007/Bf02245888  0.613
1991 Salamone JD, Steinpreis RE, McCullough LD, Smith P, Grebel D, Mahan K. Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure. Psychopharmacology. 104: 515-21. PMID 1780422 DOI: 10.1007/Bf02245659  0.793
1991 Jicha GA, Salamone JD. Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletion: possible relation to parkinsonian symptoms. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 11: 3822-9. PMID 1744692 DOI: 10.1523/Jneurosci.11-12-03822.1991  0.512
1991 Steinpreis R, Mahan K, Reser D, Salamone J. PCP-induced abnormal social behavior: Possible relation to schizophrenic pharmacology Pharmacology Biochemistry and Behavior. 39: 246. DOI: 10.1016/0091-3057(91)90532-7  0.715
1990 Salamone JD, Zigmond MJ, Stricker EM. Characterization of the impaired feeding behavior in rats given haloperidol or dopamine-depleting brain lesions. Neuroscience. 39: 17-24. PMID 2128534 DOI: 10.1016/0306-4522(90)90218-S  0.63
1990 Salamone JD, Johnson CJ, McCullough LD, Steinpreis RE. Lateral striatal cholinergic mechanisms involved in oral motor activities in the rat. Psychopharmacology. 102: 529-34. PMID 2096410 DOI: 10.1007/Bf02247136  0.809
1989 Salamone JD, Keller RW, Zigmond MJ, Stricker EM. Behavioral activation in rats increases striatal dopamine metabolism measured by dialysis perfusion. Brain Research. 487: 215-24. PMID 2786443 DOI: 10.1016/0006-8993(89)90826-3  0.638
1989 Keefe KA, Salamone JD, Zigmond MJ, Stricker EM. Paradoxical kinesia in parkinsonism is not caused by dopamine release. Studies in an animal model. Archives of Neurology. 46: 1070-5. PMID 2508609 DOI: 10.1001/Archneur.1989.00520460046012  0.766
1988 Hagan JJ, Salamone JD, Simpson J, Iversen SD, Morris RG. Place navigation in rats is impaired by lesions of medial septum and diagonal band but not nucleus basalis magnocellularis. Behavioural Brain Research. 27: 9-20. PMID 3342117 DOI: 10.1016/0166-4328(88)90105-2  0.41
1988 Welner SA, Dunnett SB, Salamone JD, MacLean B, Iversen SD. Transplantation of embryonic ventral forebrain grafts to the neocortex of rats with bilateral lesions of nucleus basalis magnocellularis ameliorates a lesion-induced deficit in spatial memory. Brain Research. 463: 192-7. PMID 3058269 DOI: 10.1016/0006-8993(88)90546-X  0.553
1988 Salamone JD. Dopaminergic involvement in activational aspects of motivation: Effects of haloperidol on schedule-induced activity, feeding, and foraging in rats Psychobiology. 16: 196-206. DOI: 10.3758/BF03327307  0.331
1986 Salamone JD, Lalies MD, Channell SL, Iversen SD. Behavioural and pharmacological characterization of the mouth movements induced by muscarinic agonists in the rat. Psychopharmacology. 88: 467-71. PMID 3085134 DOI: 10.1007/BF00178508  0.533
1986 Salamone JD. Different effects of haloperidol and extinction on instrumental behaviours. Psychopharmacology. 88: 18-23. PMID 3080774 DOI: 10.1007/BF00310507  0.392
1984 Salamone JD, Hamby LS, Neill DB, Justice JB. Extracellular ascorbic acid increases in striatum following systemic amphetamine. Pharmacology, Biochemistry, and Behavior. 20: 609-12. PMID 6728876 DOI: 10.1016/0091-3057(84)90311-3  0.605
1984 Salamone JD, Beart PM, Alpert JE, Iversen SD. Impairment in T-maze reinforced alternation performance following nucleus basalis magnocellularis lesions in rats. Behavioural Brain Research. 13: 63-70. PMID 6541050 DOI: 10.1016/0166-4328(84)90030-5  0.617
1982 Salamone JD, Lindsay WS, Neill DB, Justice JB. Behavioral observation and intracerebral electrochemical recording following administration of amphetamine in rats. Pharmacology, Biochemistry, and Behavior. 17: 445-50. PMID 6890684 DOI: 10.1016/0091-3057(82)90302-1  0.617
1981 Holdiness MR, Justice JB, Salamone JD, Neill DB. Gas chromatographic-mass spectrometric determination of glutamic acid decarboxylase activity in subregions of rat brain. Journal of Chromatography. 225: 283-90. PMID 7298766 DOI: 10.1016/S0378-4347(00)80276-5  0.561
1981 Saraswat LD, Holdiness MR, Justice JB, Salamone JD, Neill DB. Determination of dopamine, homovanillic acid and 3,4-dihydroxyphenylacetic acid in rat brain striatum by high-performance liquid chromatography with electrochemical detection. Journal of Chromatography. 222: 353-62. PMID 7228945 DOI: 10.1016/S0378-4347(00)84135-3  0.624
1980 Lindsay WS, Kizzort BL, Justice JB, Salamone JD, Neill DB. An automated electrochemical method for in vivo monitoring of catecholamine release. Journal of Neuroscience Methods. 2: 373-88. PMID 7412367 DOI: 10.1016/0165-0270(80)90004-7  0.535
1980 Lindsay WS, Kizzort BL, Justice JB, Salamone JD, Neill DB. Microcomputer Controlled Multielectrode System for in Vivo Electrochemistry Instrumentation Science & Technology. 10: 311-330. DOI: 10.1080/10739148008543499  0.525
1980 Holdiness MR, Justice JB, Neill DB, Salamone JD. Fluorimetric assay for the determination of glutamic acid decarboxylase activity in subregions of rat brain tissue Analytical Letters. 13: 1333-1344. DOI: 10.1080/00032718008081370  0.573
Low-probability matches (unlikely to be authored by this person)
2021 Errante EL, Chakkalamuri M, Akinbo OI, Yohn SE, Salamone JD, Matuszewich L. Sex differences in effort-related decision-making: role of dopamine D2 receptor antagonism. Psychopharmacology. PMID 33590311 DOI: 10.1007/s00213-021-05795-x  0.298
2018 Salamone JD. DA Neurons Promote the Instigation and Maintenance of Effortful Responding: A Commentary on Fischbach-Weiss, Reese, and Janak. Neuroscience. PMID 29337232 DOI: 10.1016/j.neuroscience.2018.01.019  0.294
2021 Porru S, López-Cruz L, Carratalá-Ros C, Salamone JD, Acquas E, Correa M. Impact of Caffeine on Ethanol Induced Stimulation and Sensitization: Changes in ERK and DARPP-32 Phosphorylation in Nucleus Accumbens. Alcoholism, Clinical and Experimental Research. PMID 33471948 DOI: 10.1111/acer.14553  0.293
2000 Salamone JD. A critique of recent studies on placebo effects of antidepressants: importance of research on active placebos. Psychopharmacology. 152: 1-6. PMID 11041309 DOI: 10.1007/s002130000509  0.292
2021 Presby R, Rotolo R, Hurley E, Ferrigno S, Murphy C, McMullen H, Desai P, Zorda E, Kuperwasser F, Carratala-Ros C, Correa M, Salamone J. Sex differences in lever pressing and running wheel tasks of effort-based choice behavior in rats: suppression of high effort activity by the serotonin transport inhibitor fluoxetine. Pharmacology, Biochemistry, and Behavior. 173115. PMID 33493546 DOI: 10.1016/j.pbb.2021.173115  0.288
2013 Markou A, Salamone JD, Bussey TJ, Mar AC, Brunner D, Gilmour G, Balsam P. Measuring reinforcement learning and motivation constructs in experimental animals: relevance to the negative symptoms of schizophrenia. Neuroscience and Biobehavioral Reviews. 37: 2149-65. PMID 23994273 DOI: 10.1016/j.neubiorev.2013.08.007  0.286
2017 Salamone JD, Correa M, Yohn SE, Yang J, Somerville M, Rotolo RA, Presby RE. Behavioral activation, effort-based choice, and elasticity of demand for motivational stimuli: Basic and translational neuroscience approaches. Motivation Science. 3: 208-229. DOI: 10.1037/mot0000070  0.284
2023 Salamone JD, Correa M. The Neurobiology of Activational Aspects of Motivation: Exertion of Effort, Effort-Based Decision Making, and the Role of Dopamine. Annual Review of Psychology. PMID 37788571 DOI: 10.1146/annurev-psych-020223-012208  0.282
2018 Ferré S, Díaz-Ríos M, Salamone JD, Prediger RD. New Developments on the Adenosine Mechanisms of the Central Effects of Caffeine and Their Implications for Neuropsychiatric Disorders. Journal of Caffeine and Adenosine Research. 8: 121-131. PMID 30596206 DOI: 10.1089/caff.2018.0017  0.275
2016 Yohn SE, Arif Y, Haley A, Tripodi G, Baqi Y, Müller CE, Miguel NS, Correa M, Salamone JD. Effort-related motivational effects of the pro-inflammatory cytokine interleukin-6: pharmacological and neurochemical characterization. Psychopharmacology. PMID 27497935 DOI: 10.1007/S00213-016-4392-9  0.273
2022 Presby RE, Rotolo RA, Katz S, Sarwat Z, Correa M, Salamone JD. Lipopolysaccharide-induced changes in effort-related motivational function: Interactions with 2-deoxyglucose. Physiology & Behavior. 258: 114005. PMID 36283457 DOI: 10.1016/j.physbeh.2022.114005  0.272
2018 Haro Cortés G, Renau-Lagranja J, Costumero V, Baquero A, Meneu E, Salamone J, Correa M. Demotivating outcome of asymmetrical Nucleus Accumbens disconnection for cocaine related disorder: a translational point of view. Adicciones. 30: 306-308. PMID 30059593 DOI: 10.20882/adicciones.1119  0.27
2013 San Miguel N, López-Cruz L, Bayarri P, Monferrer L, Salamone JD, Correa M. F.7 - IMPACT OF CAFFEINE ON VOLUNTARY ETHANOL INTAKE AND THE ALCOHOL DEPRIVATION EFFECT IN MICE Behavioural Pharmacology. 24: e51. DOI: 10.1097/01.fbp.0000434853.71031.92  0.268
2023 Ecevitoglu A, Edelstein GA, Presby RE, Rotolo RA, Yang JH, Quiles T, Okifo K, Conrad RT, Kovach A, Correa M, Salamone JD. Effects of the atypical antipsychotic and D3/D2 dopamine partial agonist cariprazine on effort-based choice behavior: implications for modeling avolition. Psychopharmacology. 240: 1747-1757. PMID 37358806 DOI: 10.1007/s00213-023-06405-8  0.263
2006 Salamone JD. Will the last person who uses the term 'reward' please turn out the lights? Comments on processes related to reinforcement, learning, motivation and effort. Addiction Biology. 11: 43-4. PMID 16759335 DOI: 10.1111/j.1369-1600.2006.00011.x  0.26
2023 Carratalá-Ros C, Martínez-Verdú A, Olivares-García R, Salamone JD, Correa M. Effects of the dopamine depleting agent tetrabenazine in tests evaluating different components of depressive-like behavior in mice: sex-dependent response to antidepressant drugs with SERT and DAT blocker profiles. Psychopharmacology. 240: 1615-1628. PMID 37407727 DOI: 10.1007/s00213-023-06412-9  0.257
2011 Salamone JD. A role for accumbens neurons in exertion of effort and evaluating effort-related costs of instrumental actions (Commentary on Day et al.). The European Journal of Neuroscience. 33: 306-7. PMID 21241383 DOI: 10.1111/j.1460-9568.2010.07566.x  0.255
1998 Cousins MS, Corrow C, Finn M, Salamone JD. Temporal measures of human finger tapping: effects of age. Pharmacology, Biochemistry, and Behavior. 59: 445-9. PMID 9476994 DOI: 10.1016/S0091-3057(97)00443-7  0.242
1994 Badura LL, Lee A, Zinn SA, Salamone JD. Basal prolactin concentrations and tuberoinfundibular dopamine metabolism in the Siberian hamster hypothalamus: Effects of photoperiod and hypothalamic knife cuts Endocrine. 2: 1017-1022.  0.24
2013 López-Cruz L, San MN, Maria C, Bayarri P, Pardo M, Ros X, Valverde O, Ledent C, Salamone JD, Correa M. E.21 - CAFFEINE INDUCES ANXIETY AND IMPAIRS SOCIAL INTERACTION IN MICE Behavioural Pharmacology. 24: e47. DOI: 10.1097/01.fbp.0000434840.15881.a4  0.228
2022 Treadway MT, Salamone JD. Vigor, Effort-Related Aspects of Motivation and Anhedonia. Current Topics in Behavioral Neurosciences. PMID 35505057 DOI: 10.1007/7854_2022_355  0.224
2023 Matas-Navarro P, Carratalá-Ros C, Olivares-García R, Martínez-Verdú A, Salamone JD, Correa M. Sex and age differences in mice models of effort-based decision-making and anergia in depression: the role of dopamine, and cerebral-dopamine-neurotrophic-factor. Psychopharmacology. PMID 37592005 DOI: 10.1007/s00213-023-06430-7  0.218
1997 Salamone JD. Centrally-acting antagonist of muscarinic M4 receptors Expert Opinion On Therapeutic Targets. 1: 93-95. DOI: 10.1517/14728222.1.1.93  0.2
2022 Salamone JD, Correa M. Critical review of RDoC approaches to the study of motivation with animal models: effort valuation/willingness to work. Emerging Topics in Life Sciences. PMID 36218385 DOI: 10.1042/ETLS20220008  0.196
2019 Salamone JD, Correa M. Patterns of Neural Responses, Pavlovian-to-Instrumental Transfer, and Prediction of Relapse. Biological Psychiatry. 86: 807-808. PMID 31668220 DOI: 10.1016/j.biopsych.2019.09.015  0.192
2013 Correa M, López-Cruz L, Bayarri P, Pardo M, San Miguel N, Ros X, Salamone JD. S.2.4 - RUNNERS VS. COUCH POTATOES Behavioural Pharmacology. 24: e3-e4. DOI: 10.1097/01.FBP.0000434689.20001.E8  0.186
2017 Acabchuk RL, Kamath J, Salamone JD, Johnson BT. Stress and chronic illness: The inflammatory pathway. Social Science & Medicine (1982). PMID 28552293 DOI: 10.1016/J.Socscimed.2017.04.039  0.181
2015 Salamone JD, Podurgiel SJ, Long LL, Nunes EJ, Correa M. opamine/adenosine interactions related to tremor in animal models of parkinsonism The Adenosinergic System: a Non-Dopaminergic Target in Parkinson's Disease. 149-162. DOI: 10.1007/978-3-319-20273-0_8  0.172
2020 Porru S, Maccioni R, Bassareo V, Peana AT, Salamone JD, Correa M, Acquas E. Effects of caffeine on ethanol-elicited place preference, place aversion and ERK phosphorylation in CD-1 mice. Journal of Psychopharmacology (Oxford, England). 269881120965892. PMID 33103552 DOI: 10.1177/0269881120965892  0.165
2021 Salamone JD. Differentiating effort-related aspects of motivation from reinforcement learning: commentary on Soder et al. "Dose-response effects of d-amphetamine on effort-based decision-making and reinforcement learning". Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 33623107 DOI: 10.1038/s41386-020-00930-2  0.14
1987 SAUNDERS J, SHOWELL GA, BAKER R, FREEDMAN SB, HILL D, MCKNIGHT A, NEWBERRY N, SALAMONE JD, HIRSHFIELD J, SPRINGER JP. ChemInform Abstract: Synthesis and Characterization of All Four Isomers of the Muscarinic Agonist 2′-Methylspiro(1-azabicyclo(2.2.2)octane-3,4′-(1,3)dioxolane) (I). Cheminform. 18. DOI: 10.1002/CHIN.198747338  0.133
2014 Correa M, San Miguel N, López-Cruz L, Bayarri P, Monferrer L, Salamone JD. Caffeine modulation of alcohol intake: Impact on its psychomotor effects and withdrawal Caffeine: Consumption, Side Effects and Impact On Performance and Mood. 89-112.  0.103
1987 Saunders J, Showell GA, Baker R, Freedman SB, Hill D, McKnight A, Newberry N, Salamone JD, Hirshfield J, Springer JP. Synthesis and characterization of all four isomers of the muscarinic agonist 2'-methylspiro[1-azabicyclo[2.2.2]octane-3,4'-[1,3]dioxolane]. Journal of Medicinal Chemistry. 30: 969-75. PMID 3585909 DOI: 10.1021/Jm00389A003  0.102
2021 Fuertes-Saiz A, Correa M, Salamone J, Salais L, Pérez-Saldaña MT, Haro G. Parkinson's disease after psychosurgery for the treatment of cocaine addiction. Adicciones. 33: 273-276. PMID 33768270 DOI: 10.20882/adicciones.1614  0.1
1983 Jaramillo A, Lopez S, Justice JB, Salamone JD, Darryl DB. Acetycholine and choline ion-selective microelectrodes Analytica Chimica Acta. 146: 149-159. DOI: 10.1016/S0003-2670(00)80601-7  0.099
2022 Gipson CD, Soto PL, Calipari ES, Platt DM, Salamone JD, Bevins RA. Using complex behavior to understand brain mechanisms in health and disease. Journal of the Experimental Analysis of Behavior. PMID 35437760 DOI: 10.1002/jeab.762  0.093
1986 Salamone JD. Behavioural functions of nucleus basalis magnocellularis and its relationship to dementia Trends in Neurosciences. 9: 256-258. DOI: 10.1016/0166-2236(86)90071-8  0.092
1980 Lindsay WS, Justice JB, Salamone J. Simulation studies of in vivo electrochemistry Computers and Chemistry. 4: 19-26. DOI: 10.1016/0097-8485(80)85005-4  0.052
2010 Salamone JD. Facing dyskinesia in Parkinson's disease: Nondopaminergic approaches Drugs of the Future. 35: 567-573. DOI: 10.1358/dof.2010.035.07.1516041  0.046
2023 Raizen DM, Mullington J, Anaclet C, Clarke G, Critchley H, Dantzer R, Davis R, Drew KL, Fessel J, Fuller PM, Gibson EM, Harrington M, Lipkin WI, Klerman EB, Klimas N, ... ... Salamone JD, et al. Beyond the Symptom: The Biology of Fatigue. Sleep. PMID 37224457 DOI: 10.1093/sleep/zsad069  0.044
1996 SALAMONE JD, COUSINES MS. COMPARATIVE RESEARCH ON CHILDHOOD HYPERKINESIS/-ATTENTION DEFICIT DISORDER Behavioural Pharmacology. 7: 98. DOI: 10.1097/00008877-199605001-00224  0.033
2014 Correa M, Acquas E, Salamone JD. The renaissance of acetaldehyde as a psychoactive compound: decades in the making. Frontiers in Behavioral Neuroscience. 8: 249. PMID 25100960 DOI: 10.3389/fnbeh.2014.00249  0.031
1995 Salamone JD. Book Reviews : Neurotransmitter Interactions and Cognitive Function Journal of Psychopharmacology. 9: 289-290. DOI: 10.1177/026988119500900317  0.031
1991 Alexander HR, Turnbull AD, Salamone J, Keefe D, Melendez J. Upper abdominal cancer surgery in the very elderly. Journal of Surgical Oncology. 47: 82-6. PMID 2062087 DOI: 10.1002/JSO.2930470205  0.027
2023 Acquas E, Dazzi L, Correa M, Salamone JD, Bassareo V. Editorial: Alcohol and energy drinks: is this a really good mix? Frontiers in Behavioral Neuroscience. 17: 1213723. PMID 37324521 DOI: 10.3389/fnbeh.2023.1213723  0.021
Hide low-probability matches.